Do Genomic Factors Play a Role in Diabetic Retinopathy?
Although there is strong clinical evidence that the control of blood glucose, blood pressure, and lipid level can prevent and slow down the progression of diabetic retinopathy (DR) as shown by landmark clinical trials, it has been shown that these factors only account for 10% of the risk for develop...
Main Authors: | Andrea P. Cabrera, Finny Monickaraj, Sampathkumar Rangasamy, Sam Hobbs, Paul McGuire, Arup Das |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/1/216 |
Similar Items
-
Novel pharmacotherapies in diabetic retinopathy: Current status and what's in the horizon?
by: Arup Das, et al.
Published: (2016-01-01) -
Genome-Wide Study Updates in the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN)
by: Claire E. Fishman, et al.
Published: (2019-11-01) -
Identification of Novel Genomic-Variant Patterns of OR56A5, OR52L1, and CTSD in Retinitis Pigmentosa Patients by Whole-Exome Sequencing
by: Ting-Yi Lin, et al.
Published: (2021-05-01) -
Genome-Wide Identification of Rare and Common Variants Driving Triglyceride Levels in a Nevada Population
by: Robert W. Read, et al.
Published: (2021-03-01) -
Whole-exome sequencing in 168 Korean patients with inherited retinal degeneration
by: Dae Joong Ma, et al.
Published: (2021-03-01)